Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 530 | N/A | 529 | 625 | 565 |
| Income taxes - deferred | 37 | N/A | -22 | N/A | N/A |
| Accounts receivable | -477 | N/A | -1,021 | N/A | N/A |
| Other Working Capital | -437 | 2,135 | -554 | -1,482 | -30 |
| Other Operating Activity | 1,098 | -182 | 1,174 | 557 | 685 |
| Operating Cash Flow | $752 | $1,953 | $106 | $-300 | $1,220 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -674 | -754 | -135 | -182 | -87 |
| Sale Of Investment | 555 | 8 | 980 | N/A | N/A |
| Other Investing Activity | 264 | 14 | 181 | 131 | 0 |
| Investing Cash Flow | $145 | $-732 | $1,025 | $-51 | $-87 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 184 | -247 | -187 | N/A | N/A |
| Dividend Paid | -824 | -789 | -717 | -2,281 | -470 |
| Other Financing Activity | -3,188 | -1,085 | 100 | 11,661 | 0 |
| Financing Cash Flow | $-3,828 | $-2,121 | $-804 | $9,380 | $-470 |
| Beginning Cash Position | 12,203 | 13,155 | 12,960 | 3,801 | 3,138 |
| End Cash Position | 9,272 | 12,226 | 13,155 | 12,960 | 3,801 |
| Net Cash Flow | $-2,931 | $-900 | $327 | $9,029 | $663 |
| Free Cash Flow | |||||
| Operating Cash Flow | 752 | 1,953 | 106 | -300 | 1,220 |
| Capital Expenditure | -674 | -787 | -135 | -182 | -87 |
| Free Cash Flow | 78 | 1,165 | -29 | -483 | 1,133 |